Early identification and treatment can reduce financial costs associated with spinal muscular atrophy

By | June 8, 2022
New research published in Developmental Medicine & Child Neurology indicates that early identification and treatment of patients with spinal muscular atrophy (SMA)-; a genetic disorder characterized by weakness and wasting in muscles-; can reduce the total financial costs associated with the condition.